Find policies, billing codes, payers, states, and providers
CPT 46916: Destruction of Anal Lesion Using Cryotherapy
CPT code 46916 covers destruction of anal lesions using cold agents such as liquid nitrogen or carbon dioxide. The procedure is commonly used to treat condyloma, papilloma, molluscum contagiosum, and small herpetic vesicles in outpatient settings. Nationally, this code represents a focused procedural service relevant to colorectal, dermatologic, and general surgical practices and factors into utilization, reimbursement, and access to minor operative treatments.
Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, typical sites of service, and the payer landscape. The publication summarizes common modifiers and coding considerations, comparisons to related procedural codes, and benchmarks for utilization and reimbursement where available.
This brief prepares clinicians, billing staff, and policy analysts to identify when CPT code 46916 applies, understand which payers commonly cover the service, and locate related coding and policy content in the full publication. Data not available in the input is identified where applicable.
Customize your policy alerts
Sign up for cpt 46916 policy alerts
Get alerted when payer policies referencing 46916 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 46916 describes destruction of an anal lesion (for example, condyloma, papilloma, molluscum contagiosum, or herpetic vesicle) using cold substances such as liquid nitrogen or carbon dioxide.
Service Type: Destruction procedure (cryotherapy) of anal lesion
Typical Site of Service: Outpatient procedural settings, commonly performed in ambulatory surgery centers, physician offices (colorectal surgery, dermatology, or primary care procedure rooms), or hospital outpatient departments.
Data not available in the input.